References

  1. Meda ZC, Huang CC, Sombie I, Konate L, Somda PK, Djibougou AD et al. Tuberculosis in developing countries: conditions for successful use of a decentralized approach in a rural health district. Pan Afr Med J. 2014; 17:198. PubMed | Google Scholar

  2. OMS. Tuberculose multirésistante (TB-MR). http://www.who.int/tb/challenges/mdr/fr/ Accessed on September 30, 2014. Google Scholar

  3. Zida S, Tarnagda Z, Kabore A, Zingue D, Hien H, Sanou A et al. Current status of atypical mycobacterial infections in Burkina Faso: results of a regional survey. Pan Afr Med J. 2014;17:188. PubMed | Google Scholar

  4. Ouedraogo M, Ouedraogo SM, Diagbouga S, Coulibaly G, Achi V, Domoua K et al. Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis. Rev Mal Respir. 2000;17(2):477-80. PubMed | Google Scholar

  5. Traore B, Diarra B, Dembele BP, Somboro AM, Hammond AS, Siddiqui S et al. Molecular strain typing of Mycobacterium tuberculosis complex in Bamako, Mali. Int J Tuberc Lung Dis. 2012; 16(7):911-6. PubMed | Google Scholar

  6. Saleri N, Capone S, Pietra V, De Iaco G, Del Punta V, Rizzi M et al. Outcome and predictive factors of mortality in hospitalized HIV-patients in Burkina Faso. Infection. 2009; 37(2):142-7. PubMed | Google Scholar

  7. Saleri N, Badoum G, Ouedraogo M, Dembele SM, Nacanabo R, Bonkoungou V et al. Extensively drug-resistant tuberculosis, Burkina Faso. Emerg Infect Dis. 2010;16(5):840-2. PubMed | Google Scholar

  8. Sangare L, Diande S, Badoum G, Dingtoumda B, Traore AS. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. Int J Tuberc Lung Dis. 2010;14(11):1424-9. PubMed | Google Scholar

  9. Brändli O, Rochatc T, Zellwegerd J-P. Clinique et diagnostic de la tuberculose. Forum Med Suisse. 2003;21:492-7. Google Scholar

  10. PNT Burkina Faso. Guide technique de lutte contre la tuberculose, ed.2008 ; 54-56. Google Scholar

  11. Drouillon V, Houriez F, Buze M, Lagrange P, Herrmann JL. Automated RNA amplification for the rapid identification of Mycobacterium tuberculosis complex in respiratory specimens. Pathol Biol (Paris). 2006;54(8-9):518-22. PubMed | Google Scholar

  12. Lin YH, Tai CH, Li CR, Lin CF, Shi ZY. Resistance profiles and rpoB gene mutations of Mycobacterium tuberculosis isolates in Taiwan. J Microbiol Immunol Infect. 2013; 46(4):266-70. PubMed | Google Scholar

  13. Miotto P, Saleri N, Dembele M, Ouedraogo M, Badoum G, Pinsi G et al. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. BMC Infect Dis. 2009;9:142. PubMed | Google Scholar

  14. Sheng J, Li J, Sheng G, Yu H, Huang H, Cao H et al. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J Appl Microbiol. 2008; 105(3):904-11. PubMed | Google Scholar

  15. Torres MJ, Criado A, Gonzalez N, Palomares JC, Aznar J. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis. 2002; 6(2):160-3. PubMed | Google Scholar

  16. Telenti A, Honore N, Bernasconi C, March J, Ortega A, Heym B et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol. 1997;35(3):719-23. PubMed | Google Scholar

  17. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998;79(1):3-29. PubMed | Google Scholar

  18. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009;13(11):1320-30. PubMed | Google Scholar

  19. Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006;50(8):2640-9. PubMed | Google Scholar

  20. Belay M, Ameni G, Bjune G, Couvin D, Rastogi N, Abebe F. Strain diversity of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Afar pastoral region of Ethiopia. Biomed Res Int. 2014; 2014:238532. PubMed | Google Scholar

  21. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 2003; 47(12):3799-805. PubMed | Google Scholar

  22. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994;263(5144):227-30. PubMed | Google Scholar

  23. Koeck JL, Bernatas JJ, Gerome P, Fabre M, Houmed A, Herve V et al. Epidemiology of resistance to antituberculosis drugs in Mycobacterium tuberculosis complex strains isolated from adenopathies in Djibouti: Prospective study carried out in 1999. Med Trop (Mars). 2002;62(1):70-2. PubMed | Google Scholar

  24. Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect Dis. 2012; 12:37. PubMed | Google Scholar